NCT04006613 is a NA clinical trial of Circuit Training in Multiple Sclerosis, sponsored by Fondazione Don Carlo Gnocchi Onlus.

Who is sponsoring NCT04006613?

NCT04006613 is sponsored by Fondazione Don Carlo Gnocchi Onlus.

What drugs are being tested in NCT04006613?

Interventions in NCT04006613: Circuit Training, Usual Care.

What condition does NCT04006613 study?

NCT04006613 studies Multiple Sclerosis.

Is NCT04006613 still recruiting?

NCT04006613 is currently completed. Last updated 8 July 2025.

Last reviewed 2025-07-08 · How we verify

NCT04006613

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Circuit Training on Balance in Persons With Multiple Sclerosis

Completed NA Last updated 8 July 2025

What this trial tests

NA trial testing Circuit Training in Multiple Sclerosis in 52 participants. Completed in 1 May 2025.

Timeline

26 February 2019

Primary endpoint
1 May 2025

1 May 2025

Quick facts

Lead sponsor	Fondazione Don Carlo Gnocchi Onlus
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	52
Start date	26 February 2019
Primary completion	1 May 2025
Estimated completion	1 May 2025
Sites	1 location across Italy

Drugs / interventions tested

Circuit Training
Usual Care

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Fondazione Don Carlo Gnocchi Onlus — full company profile →

Who can join

Adults 18 to 70, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate the effects of a circuit training rehabilitation program on the perceived impact of fatigue in daily life situations and on gait and balance. Half of the participants will follow the circuit training program, while the other half will follow usual care rehabilitation programs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Walk Longer! Using Wearable Inertial Sensors to Uncover Which Gait Aspects Should Be Treated to Increase Walking Endurance in People with Multiple Sclerosis.
Carpinella I, Bertoni R, Anastasi D, Cardini R, et al · · 2024 · cited 7× · PMID 39599061 · DOI 10.3390/s24227284

Verify or expand the search:

Other trials of Circuit Training

Trials testing the same drug.

NCT06943300 — Comparison of Aerobic Training and Circuit Training in Healthy Children · NA · not yet recruiting
NCT06601764 — Circuit and Resistance Training in COPD · NA · completed
NCT05777265 — The Effects of 16-Week Circuit Training in Healthy Women · NA · completed
NCT05777252 — Effects of 16-Week Circuit Training in Healthy Women · NA · completed

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Fondazione Don Carlo Gnocchi Onlus trials

Trials by the same sponsor.

NCT07252856 — Transcultural Digital Solutions in Phase III Cardiac Rehabilitation · NA · not yet recruiting
NCT07290218 — Tridimensional Robotic Assessment of Neglect in Brain Injured Patients · not yet recruiting
NCT07064226 — Validation of a Digital Intervention to Rehabilitate Cognitive Resources · NA · recruiting
NCT07130929 — Functional Electrical Stimulation to Treat Critical Neuromyopathy After Severe Stroke: a Pilot Study. · NA · recruiting
NCT07159854 — Telerehabilitation in Central and Peripheral Neurological Sequelae From Chemotherapy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04006613 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione Don Carlo Gnocchi Onlus
Last refreshed: 8 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04006613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing